Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide, Nature Medicine (2025) Tirzepatide once weekly for the treatment of obesity, New England Journal of Medicine (2022) Metabolic syndrome, Mayo Clinic (2025) Successful dietary changes correlate with weight-loss outcomes in a new dietary weight-loss program, Obesity Science and Practice (2024) Missed a dose (or more) of your GLP-1 medication
A trial on body fat mass does not transfer to colonic transit time, and a trial in functional constipation does not automatically transfer to GLP-1 users on dose escalation
Ready to level up your recovery and growth naturally
Endocrinol Diabetes Metab Case Rep
FOXO4-DRI Treatment Does Not Markedly Improve the Regenerative Potential of PDL9 Chondrocytes The regenerative potential of PDL9 chondrocytes after FOXO4-DRI treatment was assessed by 3D pellet culture
As the bodys primary breakdown product of caffeine, paraxanthine delivers most of caffeines benefits with a more consistent experience across individuals. Understanding its role offers an opportunity to refine how we harness one of the worlds most trusted stimulants
